CIK: 0002043476
申报总市值
US$1.3亿
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ADMA | Adma Biologics INC | 股票-医疗保健 | 32.48% | -11.67% | — | |
| 2 | INSM | Insmed INC | 股票-医疗保健 | 12.01% | — | -40.95% | |
| 3 | ZLAB | Zai Lab Ltd-adr | 股票-其他 | 10.77% | +1.07% | — | |
| 4 | AKRO | Akero Therapeutics INC | 股票-其他 | 9.55% | — | -4.15% | |
| 5 | ✓ | Eli Lilly & Co | 股票-其他 | 9.00% | — | — | |
| 6 | CLLS | Cellectis - Adr | 股票-其他 | 3.82% | -4.02% | — | |
| 7 | TSHA | Taysha Gene Therapies INC | 股票-其他 | 3.20% | -1.34% | +43.41% | |
| 8 | RARE | Ultragenyx Pharmaceutical In | 股票-其他 | 3.08% | -0.19% | +131.58% | |
| 9 | SGHT | Sight Sciences INC | 股票-其他 | 2.96% | -2.68% | +11.56% | |
| 10 | AURA | Aura Biosciences INC | 股票-其他 | 2.76% | +0.66% | +21.16% | |
| 11 | ASMB | Assembly Biosciences INC | 股票-其他 | 2.64% | -0.80% | -5.33% | |
| 12 | IOVA | Iovance Biotherapeutics INC | 股票-其他 | 1.99% | +0.88% | — | |
| 13 | ✓ | Ultragenyx Pharmaceutical In | 股票-其他 | 1.89% | — | +79.79% | |
| 14 | APGE | Apogee Therapeutics INC | 股票-其他 | 1.17% | -0.64% | +16.67% | |
| 15 | PRAX | Praxis Precision Medicines I | 股票-其他 | 1.13% | +0.71% | +84.21% | |
| 16 | SYRE | Spyre Therapeutics INC | 股票-其他 | 0.92% | +1.32% | +14.29% | |
| 17 | ORKA | Oruka Therapeutics INC | 股票-其他 | 0.65% | +1.05% | +28.83% |